![]() |
JOURNAL TOOLS |
eTOC |
Per abbonarsi |
Sottometti un articolo |
Segnala alla tua biblioteca |
ARTICLE TOOLS |
Publication history |
Estratti |
Permessi |
Per citare questo articolo |

I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
REVIEW Free
Giornale Italiano di Dermatologia e Venereologia 2018 February;153(1):68-76
DOI: 10.23736/S0392-0488.17.05795-9
Copyright © 2017 EDIZIONI MINERVA MEDICA
lingua: Inglese
Pathways in melanoma development
Tal H. ERLICH 1, David E. FISHER 1, 2 ✉
1 Department of Dermatology, Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA; 2 Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA
This review aimed to summarize the current advances in melanoma research and their clinical relevance. Until recently, melanoma was considered an incurable disease. However, in recent years tremendous advances have been made in therapeutics. This is due to profound understanding of the molecular pathways involved in melanoma development. Although new targets are always emerging, understanding how to overcome resistance to current treatments is of great interest.
KEY WORDS: Melanoma - Molecular targeted therapy - Immunotherapy